The halogenation of natural flavonoids, baicalein and chrysin, enhances their affinity to human protein kinase CK2

E Marzec, M Świtalska, M Winiewska‐Szajewska… - IUBMB …, 2020 - Wiley Online Library
A series of halogenated derivatives of natural flavonoids: baicalein and chrysin were
designed and investigated as possible ligands for the catalytic subunit of tumor‐associated …

Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α′, the catalytic subunits of CK2

A Baier, A Galicka, J Nazaruk, R Szyszka - Phytochemistry, 2017 - Elsevier
CK2 is a ubiquitous protein kinase involved in many cell functions. During the last years it
became an interesting target in cancer research. A series of flavonoid compounds was …

Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2

M Winiewska, M Makowska, P Maj… - Biochemical and …, 2015 - Elsevier
The interaction of human CK2α with a series of tetrabromobenzotriazole (TBBt) and
tetrabromobenzimidazole (TBBz) analogs, in which one of the bromine atoms proximal to …

Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors

Q Wang, XL Hu, W Shi, H Long, H Wang - Bioorganic & Medicinal …, 2022 - Elsevier
Protein kinase CK2 is a potential target for the discovery of anticancer drugs. Flavonoids are
reported to be effective CK2 inhibitors. Herein, based on structural trimming of flavonoids, a …

Structure-activity relationship of 7 flavonoids on recombinant human protein kinase CK2 holoenzyme.

C Li, X Liu, X Lin, X Chen - Zhong nan da xue xue bao. Yi xue ban …, 2009 - europepmc.org
Objective To observe the effect of 7 flavonoids on recombinant human protein kinase CK 2
holoenzyme activity and investigate their structure-activity relationship. Methods …

[HTML][HTML] A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors

A Schnitzler, A Gratz, A Bollacke, M Weyrich… - Pharmaceuticals, 2018 - mdpi.com
Human protein kinase CK2 is an emerging target for neoplastic diseases. Potent lead
structures for human CK2 inhibitors are derived from dibenzofuranones. Two new …

Evaluation of 3-Carboxy-4(1H)-quinolones as Inhibitors of Human Protein Kinase CK2

AG Golub, OY Yakovenko, VG Bdzhola… - Journal of medicinal …, 2006 - ACS Publications
Due to the emerging role of protein kinase CK2 as a molecule that participates not only in
the development of some cancers but also in viral infections and inflammatory failures, small …

Synthesis and biological evaluation of 2, 6-di (furan-3-yl) anthracene-9, 10-dione as an inhibitor of human protein kinase CK2

S Haidar, A Meyers, A Bollacke… - Die Pharmazie-An …, 2015 - ingentaconnect.com
Protein kinase CK2 is an emerging target for the therapeutic intervention in human diseases,
in particular in cancer. Inhibitors of this enzyme are at current in clinical trials indicating its …

Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2

AG Golub, VG Bdzhola, YV Kyshenia… - Molecular and cellular …, 2011 - Springer
Serine/threonine protein kinase CK2 controls vast variety of fundamental processes in cell
life; however, despite long period of study, its functional role is not completely determined …

[HTML][HTML] The selectivity of CK2 inhibitor quinalizarin: a reevaluation

G Cozza, A Venerando, S Sarno… - BioMed Research …, 2015 - hindawi.com
Many polyphenolic compounds have been reported to inhibit protein kinases, with special
reference to CK2, a pleiotropic serine/threonine kinase, implicated in neoplasia …